The Zambian Government has reacted to the United States’ decision to withdraw $50 million (approximately K1.4 billion) in annual health aid, following revelations of systemic theft of essential medical drugs, including antiretrovirals and anti-malaria treatments.
Speaking on Thursday, U.S. Ambassador to Zambia Michael Gonzalez said the aid suspension stemmed from Lusaka’s inadequate response to long-standing concerns about medical supply theft—first flagged as early as 2021.
He stressed that despite repeated appeals, the Zambian Government had failed to demonstrate sufficient action to curb the malpractice.
In a formal statement, the government acknowledged the U.S. concerns and reaffirmed its commitment to combating corruption in the health sector.
Minister of Health Elijah Muchima has attributed the theft problem to a legacy of past administrations and highlighted efforts made by President Hakainde Hichilema’s government since assuming office in August 2021.
One of the key interventions cited was the commissioning of a forensic audit by PricewaterhouseCoopers through the Auditor General’s Office which he says led to the suspension and removal of several top officials at the Zambia Medicines and Medical Supplies Agency (ZAMMSA), many of whom are now facing prosecution.
Dr. Muchima has assured the public that there is no crisis in drug availability. Stating that the availability of essential medicines in primary healthcare facilities has improved significantly—from under 35% to over 75% nationwide.
By Rachel Mumba
